Consensus statement on the use of acetaminophen/tramadol in Patients With moderate-severe pain

被引:0
|
作者
Samper Bernal, D. [1 ]
Alvarado Bonilla, A. [2 ]
Canovas, L. [3 ]
Carregal, A. [4 ]
Fernandez Sanchez, S. P. [5 ]
Gonzalez Mesa, J. M. [6 ]
Guillen Astete, C. [7 ]
Loscos Lopez, A. [8 ]
Lozano Martinez, A. J. [9 ]
Perez-Castejon, J. M. [10 ]
Romero-Culleres, G. [11 ,12 ]
Salido de Andres, E. [13 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Serv Anestesia, Clin Dolor, Barcelona, Spain
[2] Hosp Jerez de la Frontera, Serv Traumatol & Cirugia Ortoped, Cadiz, Spain
[3] Complexo Hosp Univ Ourense, Serv Anestesia, Unidad Dolor, Orense, Spain
[4] Complexo Hosp Univ Vigo, Serv Anestesia, Unidad Dolor, Vigo, Spain
[5] Hosp Santa Creu & Sant Pau, Unidad Reumatol, Barcelona, Spain
[6] Hosp Clin Virgen Victoria, Unidad Dolor, Malaga, Spain
[7] Hosp Univ Ramon y Cajal, Serv Reumatol, Madrid, Spain
[8] Hosp Arnau Vilanova, Serv Urgencias, Valencia, Spain
[9] Hosp Clin Univ Virgen Arrixaca, Serv Oncol Radioterap, Murcia, Spain
[10] Ctr Sociosanitario El Carme, Serv Geriatria & Cuidados Paliat Badalona Serv As, Barcelona, Spain
[11] Univ Vic, Univ Cent Catalunya UVIC UCC, Hosp Univ Fdn Althaia, Serv Med Fis & Rehabil, Barcelona, Spain
[12] Univ Int Catalunya UIC, Barcelona, Spain
[13] UGC Alcala del Rio, Seville, Spain
来源
MEDICINA DE FAMILIA-SEMERGEN | 2019年 / 45卷 / 01期
关键词
Pain; Tramadol; Paracetamol; Recommendations;
D O I
10.1016/j.semerg.2018.08.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: To present recommendations on the use of the paracetamol/tramadol (P/T) combination in patients with moderate-intense pain based on best evidence and experience. Methods: The method of nominal groups and Delphi was followed, and supported by a systematic literature review (SLR). A multidisciplinary panel of 12 experts in pain management was selected. In the first nominal group meeting, the aim, scope, users, and sections of the consensus document, were defined, along with the preliminary general recommendations. For the SLR, the inclusion and exclusion criteria, as well as the search strategies, were defined. Two reviewers selected and analyzed the articles. This evidence was discussed in a second nominal group meeting, and definitive recommendations were developed. For each recommendation, the evidence levels and grade of recommendation grades were classified according to the Oxford model, and the grade according to the Delphi technique. It was defined as an agreement if at least 70% of the participants scored >= 7 for each recommendation (1 = total disagreement to 10 = total agreement). Results: A total of 20 recommendations were produced, which covered general aspects, such as the assessment of pain, and those specific to P/T management. These latter included the indications of the P/T combination (patient profile, dosing, prescription, formulations), risk management (contraindications, precautions, interactions, concomitant use with other medications, follow-up, special situations), and patient education. Conclusions: These recommendations attempt to resolve any of the routine clinical questions, and help in the making of decisions on the use of the P/T combination in patients with moderate-intense pain. (C) 2018 Sociedad Espanola de Medicos de Atencion Primaria (SEMERGEN). Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:52 / 62
页数:11
相关论文
共 50 条
  • [1] Use of Methadone as First Line Strong Opioid for Moderate-Severe Pain
    Mosoiu, Daniela
    Sporis, Mariana
    Stanculeanu, Dana Lucia
    Toader, Elena
    Poroch, Vladimir
    Boanca, Mihaela
    Simion, Laurentiu
    REVISTA DE CHIMIE, 2017, 68 (05): : 1051 - 1054
  • [2] Prevalence of moderate-severe pain in hospitalized children
    Groenewald, Cornelius B.
    Rabbitts, Jennifer A.
    Schroeder, Darrell R.
    Harrison, Tracy E.
    PEDIATRIC ANESTHESIA, 2012, 22 (07) : 661 - 668
  • [3] Sleep apnea in moderate-severe obese patients
    Sergi M.
    Rizzi M.
    Comi A.L.
    Resta O.
    Palma P.
    De Stefano A.
    Comi D.
    Sleep and Breathing, 1999, 3 (2) : 47 - 52
  • [4] INFLUENCE OF GENETIC POLYMORPHISMS ON THE RESPONSE TO TRAMADOL AND IBUPROFEN IN PATIENTS WITH MODERATE-TO-SEVERE PAIN
    Saiz-Rodriguez, M.
    Galicia, I
    Borobia, A.
    Dapia, I
    Burgueno, M.
    Mugica, M. A. G.
    Sanz, J. A.
    Cabaleiro, T.
    Munoz-Guerra, M. F.
    Puerro, M.
    Llanos, L.
    Gomez-Sanchez, C., I
    Perez, D. M.
    Carcas, A. J.
    Abad-Santos, F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 91 - 91
  • [5] Is a Mobile Application Useful for Patients with Moderate-Severe Asthma?
    Martin, Sonia Herrero
    de Heredia, Javier Hueto Perez
    Remon, Alberto Cuesta
    Fernandez, Marisol Gomez
    Anton, Maria M.
    Cabases, Juan
    Rey, Ruth Garcia
    Rivas, Pilar Cebollero
    ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 (08): : 556 - 558
  • [6] Verapamil plus captopril in moderate-severe hypertensive patients
    MoraMacia, J
    Ocon, J
    Garrido, J
    Velasco, J
    Barcelo, P
    NEFROLOGIA, 1996, 16 (01): : 61 - 67
  • [7] Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis
    Mastroianni, Antonio
    Vangeli, Valeria
    Chidichimo, Luciana
    Urso, Filippo
    De Marco, Giuseppe
    Zanolini, Alfredo
    Greco, Francesca
    Mauro, Maria, V
    Greco, Sonia
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [8] Effect of inhaled corticosteroid use on weight (BMI) in pediatric patients with moderate-severe asthma
    Han, Jennifer
    Nguyen, John
    Kim, Yuna
    Geng, Bob
    Romanowski, Gale
    Alejandro, Lawrence
    Proudfoot, James
    Xu, Ronghui
    Leibel, Sydney
    JOURNAL OF ASTHMA, 2019, 56 (03) : 263 - 269
  • [9] USE OF STEM CELL TRANSPLANTATION FOR MODERATE-SEVERE GLANZMANN THROMBASTHENIA
    Lenzen, Alicia
    Walz, Amy
    Schneiderman, Jennifer
    Canner, Jason
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S10 - S10
  • [10] FOCUS ON TRAMADOL - A CENTRALLY ACTING ANALGESIC FOR MODERATE TO MODERATELY SEVERE PAIN
    BARKIN, RL
    FORMULARY, 1995, 30 (06): : 321 - 325